Cash · 2011–2025
Akebia Therapeutics cash
$185M+256.4% · FY2025
Akebia Therapeutics (AKBA) reported $185M in cash for fiscal 2025, +256.4% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $185M | +256.4% | Open → |
| FY20242024-12-31 | $51.9M | +20.8% | Open → |
| FY20232023-12-31 | $42.9M | −52.6% | Open → |
| FY20222022-12-31 | $90.5M | −39.6% | Open → |
| FY20212021-12-31 | $150M | −34.5% | Open → |
| FY20202020-12-31 | $229M | +55.1% | Open → |
| FY20192019-12-31 | $147M | +40.9% | Open → |
| FY20182018-12-31 | $105M | +49.2% | Open → |
| FY20172017-12-31 | $70.2M | −62.6% | Open → |
| FY20162016-12-31 | $187M | +276.3% | Open → |
| FY20152015-12-31 | $49.8M | +51.9% | Open → |
| FY20142014-12-31 | $32.8M | +54.5% | Open → |
| FY20132013-12-31 | $21.2M | +1,192.8% | Open → |
| FY20122012-12-31 | $1.6M | −67.3% | Open → |
| FY20112011-12-31 | $5.0M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +29.4%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Akebia Therapeutics cash |url=https://companiesranked.com/en/company/akebia-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Akebia Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-akebia-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Akebia Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001517022-26-000051 · August 5, 2026
{{cite web |title=Akebia Therapeutics cash — 10-Q (0001517022-26-000051) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000051/akba-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.